Dr Natacha Omer
Dr

Natacha Omer

Email: 

Background

Dr Natacha Omer is a paediatic oncologist at the Queensland Children's Hospital in Brisbane. She is specialised in solid tumours, with a spacial interest in paediatric and adolescent sarcomas, cancer immunotherapy and molecular oncology. She is undertaking a PhD in immunology studying natural killer (NK) cell immunotherapy in paediatric sarcomas at the Frazer Institute, University of Queensland, in Dr Fernando Guimaraes lab.

Availability

Dr Natacha Omer is:
Available for supervision

Fields of research

Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies) Biomedical and Clinical Sciences Cancer therapy (excl. chemotherapy and radiation therapy) Immunology Oncology and carcinogenesis Paediatrics Solid tumours Tumour immunology

Qualifications

  • Bachelor of Medicine, Université Rene Descartes Paris 5
  • Masters (Research) of Tumour Immunology, Université Rene Descartes Paris 5

Search Professor Natacha Omer’s works on UQ eSpace

21 works between 2017 and 2026
All (21) Journal Article (16) Conference Publication (5)

21 - 21 of 21 works

2017

Journal Article

Phase-II trials in osteosarcoma recurrences: a systematic review of past experience

Omer, Natacha, Le Deley, Marie-Cecile, Piperno-Neumann, Sophie, Marec-Berard, Perrine, Italiano, Antoine, Corradini, Nadege, Bellera, Carine, Brugieres, Laurence and Gaspar, Nathalie (2017). Phase-II trials in osteosarcoma recurrences: a systematic review of past experience. European Journal of Cancer, 75, 98-108. doi: 10.1016/j.ejca.2017.01.005

Phase-II trials in osteosarcoma recurrences: a systematic review of past experience

Current funding

  • 2026 - 2027
    Tumour-Activated Natural Killer cells in OSteosarcoma (TANK-OS): study of radiation-primed CAR-NK cells therapy in osteosarcoma
    ANZ Sarcoma Research Grant
    Open grant
  • 2024 - 2034
    Training Natural Killer Cells for Immunotherapy for Children, Adolescent, and Adults with Sarcoma
    Cooper Rice-Brading Foundation Ltd/Tie Dye Project
    Open grant

Past funding

  • 2025 - 2026
    First-in-field combinatorial therapy using anti-tumoral STING agonist to enhance chemotherapy effectiveness for hard-to-cure rhabdomyosarcomas
    ANZ Sarcoma Research Grant
    Open grant
  • 2024 - 2026
    Natural killer cell immunotherapy in paediatric sarcomas
    The Children's Hospital Foundation
    Open grant
  • 2024 - 2025
    NK Cell Scale Up: Training Natural Killer cells for Immunotherapy for children, adolescent and adults with Sarcoma
    The Kid's Cancer Project
    Open grant

Availability

Dr Natacha Omer is:
Available for supervision

Looking for a supervisor? Read our advice on how to choose a supervisor.

Enquiries

For media enquiries about Dr Natacha Omer's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au